Clinical trials: Unintended Pregnancy Prevention
Reproductive Health
Mid-life Women: Preventing Unintended Pregnancy and STIs
Mid-life women, aged 35-50, are currently an underserved population in the areas of unintended pregnancy and STI prevention interventions.
- Trial name
- FemRepro_2 (NCT02330133)
- Testing
- Women's Reproductive Health, Online sexual health content
- Where
- United States
- Volunteers
- 333 people, healthy volunteers welcome
- Sponsor
- Oregon Center for Applied Science, Inc.
Pregnancy, Unplanned
Impact of SH T00658ID as Compared to a Monophasic Contraceptive Containing Ethinylestradiol and Levonorgestrel (SH D01155E) on Hemostatic Parameters
The aim of this study is to evaluate the impact of SH T00658ID (EV/DNG tablet) on hemostatic parameters in comparison to a reference oral contraceptive (OC) (SH D01155E) in a crossover design.
- Trial name
- NCT00318799
- Testing
- EV/DNG (Qlaira, BAY86-5027, SH T00658ID), SH D01155E
- Where
- Netherlands
- Volunteers
- 29 people, healthy volunteers welcome
- Sponsor
- Bayer